Nektar Therapeutics | Ventas

Sales Cambio Fecha
Agios Pharmaceuticals USD 7.1M 296K 2023-12
ALKERMES USD 350.4M 27.08M 2024-03
Amgen USD 8.2B 1.29B 2023-12
Baxter International USD 3.88B 177M 2023-12
Biogen USD 2.29B 96.3M 2024-03
Bristol-Myers Squibb USD 11.9B 423M 2024-03
Cipla INR 66.04B 743.4M 2023-12
Dr.Reddys Laboratories INR 72.37B 3.34B 2023-12
Eisai JPY 177.7B 1.09B 2023-12
Eli Lilly USD 8.77B 583.4M 2024-03
Exelixis USD 425M 54.65M 2024-03
Gilead Sciences USD 7.12B 64M 2023-12
GlaxoSmithKline GBP 7.36B 692M 2024-03
Grifols EUR 1.77B 172.07M 2023-12
Halozyme Therapeutics USD 230.04M 14.01M 2023-12
Incyte USD 880.89M 132.45M 2024-03
Ionis Pharmaceuticals USD 325M 180.79M 2023-12
Ironwood Pharmaceuticals USD 117.55M 3.81M 2023-12
MacroGenics USD 10.72M 323K 2023-12
Merck USD 15.8B 1.17B 2024-03
Neurocrine Biosciences USD 515.3M 100K 2024-03
Novartis USD 11.83B 54M 2024-03
Pfizer USD 14.9B 651M 2024-03
Roche Holding CHF 28.94B 842M 2023-12
Sarepta Therapeutics USD 413.5M 16.72M 2024-03
Takeda JPY 1.11T 68.1B 2023-12
Teva Pharmaceutical Industries USD 4.46B 607M 2023-12
Xencor USD 44.69M 14.48M 2023-12



Nektar Therapeutics Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2024.